ISSN:
1540-8159
Source:
Blackwell Publishing Journal Backfiles 1879-2005
Topics:
Medicine
Notes:
In drug refractory and highly symptomatic atrial fibrillation (AF) patients, hemodynamic effects of AV node ablation and pacing therapy (APT) were evaluated. Thirty-eight patients with drug refractory and symptomatic AF, underwent APT in eight centers in Japan. The outcome of this therapy was assessed in terms of quality-of-life, cardiac performance measured by echocardiogram, and plasma ANP and BNP levels before and after APT. Quality-of-life assessed by self-administered semiquantitative questionnaires: WHO QOL 26 ( 3.0 ± 0.5 vs 3.4 ± 0.6, P 〈 0.01 ) and the Symptom Checklist: Frequency Scale ( 1.6 ± 0.6 vs 0.7 ± 0.7, P 〈 0.01 ) and Severity Scale ( 1.3 ± 0.4 vs 0.6 ± 0.6, P 〈 0.01 ), improved significantly 6 months after APT. Ejection fraction (EF) by echocardiogram improved 1 week after APT ( 59.0%± 13.3% vs 63.3%± 11.6%, P = 0.02 ). Plasma ANP levels in the group of ANP 〉 40 pg/mL at enrollment significantly decreased 1 month later (P = 0.03) , and plasma BNP levels in the group of BNP 〉 20 pg/mL at enrollment significantly decreased 1 month later (P 〈 0.01) . In conclusion, APT has beneficial hemodynamic effects, and plasma BNP levels can predict the most optimal candidates for ablation and pacing therapy. (PACE 2003; 26:1212–1217)
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1046/j.1460-9592.2003.t01-1-00171.x
Permalink